https://www.selleckchem.com/pr....oducts/hc-030031.htm
In the subgroup analysis, such benefits of adjuvant CRT over CTx was observed only in patients with head tumor vascular RM0.5mm, but not in patients with body/tail tumor or vascular RM≤0.5mm. In the CRT group, radiation dose≥54Gy was significantly associated with better TTR and OS. Adjuvant CRT could improve TTR and OS compared to adjuvant CTx alone in patients with close RM under 2mm. Radiation dose escalation may be beneficial when feasible. Modern CRT regimen-based randomized evidence is needed for these high-risk patient
Like
Comment
Share
